Let's Win Pancreatic Cancer 💜
@letswinpc
Followers
8K
Following
27K
Media
8K
Statuses
50K
Let’s Win is your guide to hope and action. Our mission is to guide pancreatic cancer patients with vital information for better outcomes. 💜
USA- National
Joined November 2015
We have a new #PancChat🎙️ Episode! Tune in 🎧 to listen to @MPishvaian discuss Treatment Options for #PancreaticCancer with host @AlisynCamerota wherever you listen to podcasts! https://t.co/mNr8SbF9w6 PancChat is a collaboration between Let's Win and @PanCAN.
0
8
17
What is tumor staging and how does it affect treatment? Dr. Shubham Pant helps explain how pancreatic cancer tumors are staged and graded.
letswinpc.org
What is tumor staging and how does it affect treatment? Dr. Shubham Pant helps explain how pancreatic cancer tumors are staged and graded.
0
0
0
What can you expect during pancreatic cancer diagnostic testing? Dr. Gobind Anand offers expert guidance to stay informed throughout the process.
letswinpc.org
What can you expect during pancreatic cancer diagnostic testing? Dr. Gobind Anand offers expert guidance to stay informed throughout the process.
0
0
0
Dr. Smith Apisarnthanarax, a radiation oncologist, details the different types of radiation therapy given to pancreatic cancer patients.
letswinpc.org
Dr. Smith Apisarnthanarax, a radiation oncologist, details the different types of radiation therapy given to pancreatic cancer patients.
0
0
0
Dr. Johanna Bendell explains the value of molecular profiling, which can indicate the best type of chemotherapy for your tumor.
letswinpc.org
Dr. Johanna Bendell explains the value of molecular profiling, which can indicate the best type of chemotherapy for your tumor.
0
0
0
How do doctors decide when to use chemotherapy, explore immunotherapy, or recommend a clinical trial? In this episode of #PancChat, host Alisyn Camerota speaks with Dr. Andrew Hendifar of @CedarsSinai about Clinical Trials for #PancreaticCancer.
0
0
0
Just checked CTSU. Thank you to the 91 sites that have already opened our study! Please reach out to me/study team with any q's re: site activation.
NRG-GI011 (LAP100) has enrolled & randomized its 1st patient (U Cincinnati)🙏 355 to go. The lead enroller will get dinner on me at ASCO/GI ASCO/ASTRO 😀
5
5
31
LLMs are getting better, faster, and smarter, and as they do, we need new ways to use them. Applications build with LLMs have transitioned from asking LLMs to write to letting LLMs drive actions. With that, comes new challenges in developing agentic applications.
0
10
50
THANK YOU to the Select Boards of #WestportMA & @TownofFairhaven for voting today to send letters of support to the Chairs of the Joint Committee on Health Care Financing on behalf of AN ACT TO REDUCE INCIDENCE AND DEATH FROM PANCREATIC CANCER (H.2432/S.1484). They joined
0
3
3
Eric Egelman had molecular profiling of his tumor and a KRAS mutation was found. This qualified him for a vaccine clinical trial. He began neoadjuvant chemo FOLFIRINOX at @NorthwellHealth and later had a robotic-assisted Whipple followed by adjuvant chemo.
letswinpc.org
Eric Egelman had molecular profiling of his tumor and a KRAS mutation was found. This qualified him for a vaccine clinical trial.
0
0
3
Artificial intelligence can have many benefits for patients and caregivers, organizing complex information, but it must be used properly.
letswinpc.org
Artificial intelligence can have many benefits for patients and caregivers, organizing complex information, but it must be used properly.
0
0
0
How do doctors decide when to use standard chemotherapy, explore immunotherapy or recommend a clinical trial? 🧪 In this episode of PancChat, host @AlisynCamerota speaks with Dr. Andrew Hendifar of @CedarsSinai about how tumor sequencing, genetic testing and emerging
0
4
8
Dr. Anup Kasi provides in-depth information and answers questions about qualifying for pancreatic cancer clinical trials.
letswinpc.org
Dr. Anup Kasi provides in-depth information and answers questions about qualifying for pancreatic cancer clinical trials.
0
0
1
An experimental pan-KRAS inhibitor reprograms the tumor microenvironment in #PDAC and potentiates T cell infiltration, and suppresses cancer growth in mouse models while sensitizing tumors to checkpoint blockade. @Aiims1742 @KalluriLab @mcandrews_kate
https://t.co/wOsZcVAUX6
2
7
26
Please join the Harvard Medical School Center for Palliative Care for its new Foundations of Palliative Care course ( https://t.co/Yf8ygzt0KY). Foundations of Palliative Care is led by an interprofessional team from Harvard Medical School-affiliated clinicians. The course is
0
4
8
Russell Reed learned to advocate for himself and shares six important points that he learned on his treatment journey.
letswinpc.org
Russell Reed learned to advocate for himself and shares six important points that he learned on his treatment journey.
0
0
0
🚭 How does smoking promote #PancreaticCancer? This @CD_AACR paper by @timofran1 @UMICHpancreas shows that 🚬 ⬆️ Aryl hydrocarbon receptor (AhR) ligands like TCCD, which drive polarization of CD4+ T cells & accumulation of immune suppressive Tregs. https://t.co/n6KN8vZSm6
0
14
35
Chair-Elect @RyanNipp MD, MPH, FASCO, attended @ASCO Quality as a trainee, and the science, education, and community he found there has kept him coming back. “For many of us, it is our favorite meeting of the year." #ascoQLTY25
https://t.co/MHLfVCozoC
dailynews.ascopubs.org
The 2025 ASCO Quality Care Symposium (QCS) will take place on October 10 and 11 and focus on the theme of “Driving Solutions, Implementing Change.” The Symposium includes sessions on shared decisio...
0
9
33
Dr. Allyson Ocean and Dr. Jordan Winter explain why getting a second opinion can be of great benefit for pancreatic cancer patients.
letswinpc.org
Dr. Allyson Ocean and Dr. Jordan Winter explain why getting a second opinion can be of great benefit for pancreatic cancer patients.
0
0
0
What should I eat while in treatment? Oncology dietitian Maria Petzel provides eating strategies for pancreatic cancer patients.
letswinpc.org
What should I eat while in treatment? Oncology dietitian Maria Petzel provides eating strategies for pancreatic cancer patients.
0
0
0
A new clinical trial is testing a triple-drug combo (nab-paclitaxel, gemcitabine, and cisplatin) for metastatic pancreatic cancer patients with BRCA1/2 or PALB2 mutations. If you've had previous treatments but not cisplatin, this could be for you.
letswinpc.org
A clinical trial is comparing a two-drug combination with a three-drug combination to see which works better for genetic mutations.
0
0
0
Raji Shameem, MD, discusses considerations for selecting between available chemotherapy regimens for patients with advanced pancreatic cancer. https://t.co/UsoctDT8Lt via @OncLive
onclive.com
Raji Shameem, MD, discusses considerations for selecting between available chemotherapy regimens for patients with advanced pancreatic cancer.
0
0
0